Recently the American Urological Association (AUA) announced new guidelines for prostate specific antigen (PSA) testing. These guidelines were designed to help urologists, and ultimately patients, reduce prostate cancer mortality by making informed screening decisions. These recommendations were based on comprehensive literature reviews and the strength of the existing evidence.
